サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1300791

周産期感染症の世界市場規模調査＆予測：感染タイプ別、診断別、治療別、投与経路別、エンドユーザー別、地域別分析、2023-2030年

Global Perinatal Infections Market Size Study & Forecast, by Infection Type, By Diagnosis, By Treatment, By Route of Administration, By End-user, and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.06円
周産期感染症の世界市場規模調査＆予測：感染タイプ別、診断別、治療別、投与経路別、エンドユーザー別、地域別分析、2023-2030年
出版日: 2023年06月27日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

周産期感染症とは、妊娠中または分娩直後に起こる感染症で、母体から胎児や新生児に感染する可能性があります。

これらの感染症は一般に、細菌、ウイルス、真菌、寄生虫によって引き起こされ、母体と胎児の両方に深刻な影響を及ぼします。一般的な周産期感染症には、サイトメガロウイルス感染症、エンテロウイルス感染症、性器ヘルペス、淋病、ヒト免疫不全ウイルスなどがあります。周産期感染症患者の急増、治療可能性に関する意識の高まり、政府イニシアチブの増加、個別化医療への需要の高まり、ポイントオブケア検査への傾向の高まりは、世界中の市場需要を促進している最も顕著な要因です。

加えて、ヒト免疫不全ウイルス（HIV）の罹患率の上昇は、世界中の市場成長にプラスの影響を与えています。HIVに感染した妊婦は、ウイルスの母子感染リスクを低減するために抗レトロウイルス療法（ART）を必要とします。適切な治療が行われなければ、感染のリスクは高く、周産期HIV感染につながり、新生児に深刻な健康被害をもたらす可能性があります。HIV.govによると、2021年には世界で約3,840万人がHIVに感染し、そのうち170万人が小児（15歳未満）、3,670万人が成人であると推定されています。また、2021年には世界中で約150万人がHIVに感染しています。これにより、HIVの予防と治療に対する認識と取り組みが高まり、ARTが利用できるようになったことは、周産期HIV感染の可能性を減少させる助けとなり、ひいては世界市場の成長を加速させます。さらに、小売薬局の需要の高まりと診断検査における技術の進歩により、今後数年間にわたってさまざまな収益機会がもたらされます。しかし、熟練した専門家の不足と治療に伴う高コストが、2023-2030年の予測期間を通じて市場成長の妨げとなっています。

世界の周産期感染症市場の調査で考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカなどです。北米は、ポイントオブケア検査への嗜好の高まり、政府のイニシアチブの増加、個別化医療への需要の促進により、2022年の市場を独占しました。一方、アジア太平洋地域は予測期間中に最も高いCAGRで成長すると予想されます。周産期感染症の急増、治療可能性に関する意識の高まり、小売薬局の需要の増加、医療支出の増加が、この地域全体の市場需要を大きく促進しています。

本調査の目的は、近年のさまざまなセグメントおよび国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界市場・セグメント別市場推計・予測、2020-2030年
    • 周産期感染症市場：地域別、2020-2030年
    • 周産期感染症市場：感染タイプ別、2020-2030年
    • 周産期感染症市場：診断別、2020-2030年
    • 周産期感染症市場：治療別、2020-2030年
    • 周産期感染症市場：投与経路別、2020-2030年
    • 周産期感染症市場：エンドユーザー別、2020-2030年
  • 主要動向
  • 調査手法
  • 調査前提条件

第2章 世界の周産期感染症市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 世界の周産期感染症市場力学

  • 周産期感染症市場のインパクト分析（2020-2030年）
    • 市場促進要因
      • 周産期感染症の急増
      • ヒト免疫不全ウイルス（HIV）の増加
    • 市場の課題
      • 熟練した専門家の不足
      • 治療費の高騰
    • 市場機会
      • 小売薬局の需要の高まり
      • 診断検査における技術進歩の増加

第4章 世界の周産期感染症市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 周産期感染症の世界市場：感染タイプ別

  • 市場スナップショット
  • 周産期感染症の世界市場：感染タイプ別、業績 - ポテンシャル分析
  • 周産期感染症の世界市場：感染タイプ別、推定・予測、2020-2030年
  • 周産期感染症市場、サブセグメント別分析
    • サイトメガロウイルス感染症
    • エンテロウイルス感染症
    • 性器ヘルペス
    • 淋菌感染症
    • ヒト免疫不全ウイルス
    • その他

第6章 周産期感染症の世界市場：診断別

  • 市場スナップショット
  • 周産期感染症の世界市場：診断別、業績、ポテンシャル分析
  • 周産期感染症の世界市場：診断別、推定・予測、2020-2030年
  • 周産期感染症市場、サブセグメント別分析
    • 母体検査
    • 新生児検査
    • その他

第7章 周産期感染症の世界市場：治療別

  • 市場スナップショット
  • 周産期感染症の世界市場：治療別、実績 - ポテンシャル分析
  • 周産期感染症の世界市場：治療別、推定・予測、2020-2030年
  • 周産期感染症市場、サブセグメント別分析
    • 抗生物質
    • 抗ウイルス剤
    • 抗レトロウイルス薬
    • その他

第8章 周産期感染症の世界市場：投与経路別

  • 市場スナップショット
  • 周産期感染症の世界市場：投与経路別、業績-ポテンシャル分析
  • 周産期感染症の世界市場：投与経路別、推定・予測、2020-2030年
  • 周産期感染症市場、サブセグメント別分析
    • 経口
    • 非経口
    • その他

第9章 周産期感染症市場：エンドユーザー別

  • 市場スナップショット
  • 周産期感染症の世界市場：エンドユーザー別、業績-ポテンシャル分析
  • 周産期感染症の世界市場：エンドユーザー別、推定・予測、2020-2030年
  • 周産期感染症市場、サブセグメント別分析
    • 病院
    • 在宅医療
    • 専門クリニック

第10章 周産期感染症の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 周産期感染症市場、地域別市場スナップショット
  • 北米
    • 米国
      • 感染タイプ別、推定・予測、2020-2030年
      • 診断別、推定・予測、2020-2030年
      • 治療別、推定・予測、2020～2030年
      • 投与経路別、推定・予測、2020-2030年
      • エンドユーザー別、推定・予測、2020-2030年
    • カナダ
  • 欧州の周産期感染症市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の周産期感染症市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカの周産期感染症市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東・アフリカ

第11章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Merck KGaA（Germany）
      • 主要情報
      • 概要
      • 財務（データの入手が可能な場合）
      • 製品概要
      • 最近の動向
    • Beckman Coulter Inc.（U.S.）
    • BIOMERIEUX（France）
    • Bio-Rad Laboratories, Inc（U.S.）
    • Danaher（U.S.）
    • Hologic Inc.（U.S.）
    • Gilead Sciences, Inc.（U.S.）
    • Emcure Pharmaceuticals Limited.（India）
    • Cipla Inc.（U.S.）
    • Johnson & Johnson Private Limited（U.S.）

第12章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Perinatal Infections Market, report scope
  • TABLE 2. Global Perinatal Infections Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Perinatal Infections Market estimates & forecasts by Infection Type 2020-2030 (USD Billion)
  • TABLE 4. Global Perinatal Infections Market estimates & forecasts by Diagnosis 2020-2030 (USD Billion)
  • TABLE 5. Global Perinatal Infections Market estimates & forecasts by Treatment 2020-2030 (USD Billion)
  • TABLE 6. Global Perinatal Infections Market estimates & forecasts by Route of Administration 2020-2030 (USD Billion)
  • TABLE 7. Global Perinatal Infections Market estimates & forecasts by End-user 2020-2030 (USD Billion)
  • TABLE 8. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Perinatal Infections Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. Global Perinatal Infections Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 19. U.S. Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. U.S. Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 22. Canada Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. Canada Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 25. UK Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. UK Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 28. Germany Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. Germany Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 31. France Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. France Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 34. Italy Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Italy Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 37. Spain Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. Spain Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 40. RoE Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. RoE Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 43. China Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. China Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 46. India Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. India Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 49. Japan Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. Japan Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 52. South Korea Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. South Korea Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 55. Australia Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. Australia Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. RoAPAC Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 61. Brazil Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Brazil Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 64. Mexico Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. Mexico Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 67. RoLA Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. RoLA Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. Saudi Arabia Perinatal Infections Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 70. South Africa Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. RoMEA Perinatal Infections Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 72. List of secondary sources, used in the study of global Perinatal Infections Market
  • TABLE 73. List of primary sources, used in the study of global Perinatal Infections Market
  • TABLE 74. Years considered for the study
  • TABLE 75. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Perinatal Infections Market, research methodology
  • FIG 2. Global Perinatal Infections Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Perinatal Infections Market, key trends 2022
  • FIG 5. Global Perinatal Infections Market, growth prospects 2023-2030
  • FIG 6. Global Perinatal Infections Market, porters 5 force model
  • FIG 7. Global Perinatal Infections Market, pest analysis
  • FIG 8. Global Perinatal Infections Market, value chain analysis
  • FIG 9. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Perinatal Infections Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Perinatal Infections Market, regional snapshot 2020 & 2030
  • FIG 15. North America Perinatal Infections Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Perinatal Infections Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Perinatal Infections Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Perinatal Infections Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Perinatal Infections Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Perinatal Infections Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Perinatal infections are infections that occur during pregnancy or shortly after delivery, which can be transmitted from the mother to the fetus or newborn. These infections is generally caused by bacteria, viruses, fungi, or parasites that exhibit a serious impact on both the mother and the infant. Several common perinatal infections include cytomegalovirus infection, enterovirus infection, genital herpes, gonorrhea, human immunodeficiency virus, others. The surging cases of perinatal infections, growing awareness regarding treatment availability, rising number of government initiatives, spurring demand for personalized medicine, rising inclination towards point-of-care testing are the most prominent factors that are propelling the market demand across the globe.

In addition, the rising incidences of Human Immunodeficiency Virus (HIV) are exhibiting a positive influence on market growth across the globe. Pregnant women with HIV require antiretroviral therapy (ART) to reduce the risk of mother-to-child transmission of the virus. Without proper treatment, the risk of transmission is high and leads to perinatal HIV infection, which can have serious health consequences for the newborn. According to HIV.gov, in 2021it was estimated that nearly 38.4 million people worldwide are suffering from HIV, of which 1.7 million were children (<15 years old) and 36.7 million were adults. Also, in 2021, approximately 1.5 million individuals around the globe acquired HIV. Thereby, the growing awareness and initiatives for HIV prevention and treatment, along with the availability of ART is aids in lessening the chances of perinatal HIV infection, which, in turn, accelerates the global market growth. Moreover, the growing demand for retail pharmacies, as well as the increasing technological advancements in diagnostic tests presents various lucrative opportunities over the forecasting years. However, the lack of skilled professionals and high cost involved in treatment are hindering the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Perinatal Infections Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing preference towards point-of-care testing, rising number of government initiatives, and spurring demand for personalized medicine. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The surging cases of perinatal infections, growing awareness regarding treatment availability, increasing demand for retail pharmacies, and rising healthcare spending are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Merck KGaA (Germany)
  • Beckman Coulter Inc. (U.S.)
  • BIOMERIEUX (France)
  • Bio-Rad Laboratories, Inc (U.S.)
  • Danaher (U.S.)
  • Hologic Inc. (U.S.)
  • Gilead Sciences, Inc. (U.S.)
  • Emcure Pharmaceuticals Limited. (India)
  • Cipla Inc. (U.S.)
  • Johnson & Johnson Private Limited (U.S.)

Recent Developments in the Market:

  • In October 2021, Gilead Sciences, Inc. unveiled that the Biktarvy (bictegravir 30 mg/emtricitabine 120 mg/tenofovir alafenamide 15 mg tablets) has received U.S. Food and Drug Administration (FDA) approval for a new low-dose tablet dosage form for children and adolescents that are virologically suppressed or new to antiretroviral therapy and weigh between 14 kg and 25 kg. By approving this supplemental New Drug Application (sNDA), Biktarvy's indication has been extended to encompass younger children who are HIV-infected, bridging the gap between paediatric and adult HIV treatment alternatives.

Global Perinatal Infections Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Infection Type, Diagnosis, Treatment, Route of Administration, End-user, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Infection Type:

  • Cytomegalovirus Infection
  • Enterovirus Infection
  • Genital Herpes
  • Gonorrhoea
  • Human Immunodeficiency Virus
  • Others

By Diagnosis:

  • Maternal Test
  • Neonatal Test
  • Others

By Treatment:

  • Antibiotics
  • Antiviral
  • Antiretroviral
  • Others

By Route of Administration:

  • Oral
  • Parenteral
  • Others

By End-user:

  • Hospitals
  • Homecare
  • Specialty Clinics

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Perinatal Infections Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Perinatal Infections Market, by Infection Type, 2020-2030 (USD Billion)
    • 1.2.3. Perinatal Infections Market, by Diagnosis, 2020-2030 (USD Billion)
    • 1.2.4. Perinatal Infections Market, by Treatment, 2020-2030 (USD Billion)
    • 1.2.5. Perinatal Infections Market, by Route of Administration, 2020-2030 (USD Billion)
    • 1.2.6. Perinatal Infections Market, by End-user, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Perinatal Infections Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Perinatal Infections Market Dynamics

  • 3.1. Perinatal Infections Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Surging cases of perinatal infections
      • 3.1.1.2. Rising incidences of Human Immunodeficiency Virus (HIV)
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of skilled professionals
      • 3.1.2.2. High cost involved in the treatment
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing demand for retail pharmacies
      • 3.1.3.2. Increasing technological advancements in diagnostic tests

Chapter 4. Global Perinatal Infections Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Perinatal Infections Market, by Infection Type

  • 5.1. Market Snapshot
  • 5.2. Global Perinatal Infections Market by Infection Type, Performance - Potential Analysis
  • 5.3. Global Perinatal Infections Market Estimates & Forecasts by Infection Type 2020-2030 (USD Billion)
  • 5.4. Perinatal Infections Market, Sub Segment Analysis
    • 5.4.1. Cytomegalovirus Infection
    • 5.4.2. Enterovirus Infection
    • 5.4.3. Genital Herpes
    • 5.4.4. Gonorrhoea
    • 5.4.5. Human Immunodeficiency Virus
    • 5.4.6. Others

Chapter 6. Global Perinatal Infections Market, by Diagnosis

  • 6.1. Market Snapshot
  • 6.2. Global Perinatal Infections Market by Diagnosis, Performance - Potential Analysis
  • 6.3. Global Perinatal Infections Market Estimates & Forecasts by Diagnosis 2020-2030 (USD Billion)
  • 6.4. Perinatal Infections Market, Sub Segment Analysis
    • 6.4.1. Maternal Test
    • 6.4.2. Neonatal Test
    • 6.4.3. Others

Chapter 7. Global Perinatal Infections Market, by Treatment

  • 7.1. Market Snapshot
  • 7.2. Global Perinatal Infections Market by Treatment, Performance - Potential Analysis
  • 7.3. Global Perinatal Infections Market Estimates & Forecasts by Treatment 2020-2030 (USD Billion)
  • 7.4. Perinatal Infections Market, Sub Segment Analysis
    • 7.4.1. Antibiotics
    • 7.4.2. Antiviral
    • 7.4.3. Antiretroviral
    • 7.4.4. Others

Chapter 8. Global Perinatal Infections Market, by Route of Administration

  • 8.1. Market Snapshot
  • 8.2. Global Perinatal Infections Market by Route of Administration, Performance - Potential Analysis
  • 8.3. Global Perinatal Infections Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
  • 8.4. Perinatal Infections Market, Sub Segment Analysis
    • 8.4.1. Oral
    • 8.4.2. Parenteral
    • 8.4.3. Others

Chapter 9. Perinatal Infections Market, by End-user

  • 9.1. Market Snapshot
  • 9.2. Global Perinatal Infections Market by End-user, Performance - Potential Analysis
  • 9.3. Global Perinatal Infections Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
  • 9.4. Perinatal Infections Market, Sub Segment Analysis
    • 9.4.1. Hospitals
    • 9.4.2. Homecare
    • 9.4.3. Specialty Clinics

Chapter 10. Global Perinatal Infections Market, Regional Analysis

  • 10.1. Top Leading Countries
  • 10.2. Top Emerging Countries
  • 10.3. Perinatal Infections Market, Regional Market Snapshot
  • 10.4. North America Perinatal Infections Market
    • 10.4.1. U.S. Perinatal Infections Market
      • 10.4.1.1. Infection Type breakdown estimates & forecasts, 2020-2030
      • 10.4.1.2. Diagnosis breakdown estimates & forecasts, 2020-2030
      • 10.4.1.3. Treatment breakdown estimates & forecasts, 2020-2030
      • 10.4.1.4. Route of Administration breakdown estimates & forecasts, 2020-2030
      • 10.4.1.5. End-user breakdown estimates & forecasts, 2020-2030
    • 10.4.2. Canada Perinatal Infections Market
  • 10.5. Europe Perinatal Infections Market Snapshot
    • 10.5.1. U.K. Perinatal Infections Market
    • 10.5.2. Germany Perinatal Infections Market
    • 10.5.3. France Perinatal Infections Market
    • 10.5.4. Spain Perinatal Infections Market
    • 10.5.5. Italy Perinatal Infections Market
    • 10.5.6. Rest of Europe Perinatal Infections Market
  • 10.6. Asia-Pacific Perinatal Infections Market Snapshot
    • 10.6.1. China Perinatal Infections Market
    • 10.6.2. India Perinatal Infections Market
    • 10.6.3. Japan Perinatal Infections Market
    • 10.6.4. Australia Perinatal Infections Market
    • 10.6.5. South Korea Perinatal Infections Market
    • 10.6.6. Rest of Asia Pacific Perinatal Infections Market
  • 10.7. Latin America Perinatal Infections Market Snapshot
    • 10.7.1. Brazil Perinatal Infections Market
    • 10.7.2. Mexico Perinatal Infections Market
  • 10.8. Middle East & Africa Perinatal Infections Market
    • 10.8.1. Saudi Arabia Perinatal Infections Market
    • 10.8.2. South Africa Perinatal Infections Market
    • 10.8.3. Rest of Middle East & Africa Perinatal Infections Market

Chapter 11. Competitive Intelligence

  • 11.1. Key Company SWOT Analysis
    • 11.1.1. Company 1
    • 11.1.2. Company 2
    • 11.1.3. Company 3
  • 11.2. Top Market Strategies
  • 11.3. Company Profiles
    • 11.3.1. Merck KGaA (Germany)
      • 11.3.1.1. Key Information
      • 11.3.1.2. Overview
      • 11.3.1.3. Financial (Subject to Data Availability)
      • 11.3.1.4. Product Summary
      • 11.3.1.5. Recent Developments
    • 11.3.2. Beckman Coulter Inc. (U.S.)
    • 11.3.3. BIOMERIEUX (France)
    • 11.3.4. Bio-Rad Laboratories, Inc (U.S.)
    • 11.3.5. Danaher (U.S.)
    • 11.3.6. Hologic Inc. (U.S.)
    • 11.3.7. Gilead Sciences, Inc. (U.S.)
    • 11.3.8. Emcure Pharmaceuticals Limited. (India)
    • 11.3.9. Cipla Inc. (U.S.)
    • 11.3.10. Johnson & Johnson Private Limited (U.S.)

Chapter 12. Research Process

  • 12.1. Research Process
    • 12.1.1. Data Mining
    • 12.1.2. Analysis
    • 12.1.3. Market Estimation
    • 12.1.4. Validation
    • 12.1.5. Publishing
  • 12.2. Research Attributes
  • 12.3. Research Assumption